Adult burn wounds, which lack hyaluronan (HA), often undergo excessive tissue remodeling and contraction. In contrast fetal wounds, which contain large amounts of HA, undergo remodeling that culminates in a scarless repair or regeneration. Therefore, adding a HA derivative to burn wounds would better mimic the fetal extracellular matrix and could reduce contraction. To test this hypothesis, we determined the effects of HA and its two derivatives on fibroblast-mediated, collagen gel contraction, an assay widely used to mimic in vivo wound contraction. Interestingly, high molecular weight HA (HMW HA) facilitated collagen gel contraction, whereas a thiol-functionalized derivative HA-DTPH weakly inhibited contraction. In contrast, polyethylene glycol diacrylate (PEGDA)-crosslinked HA-DTPH (HA-DTPH-PEGDA) strongly inhibited contraction in a concentration-dependent manner. Immunofluorescence staining of cellular actin showed that this inhibition was not owing to reduced cell attachment or spreading. Furthermore, the supernatant of contracted collagen-HMW HA gels contained greater amounts of HA than those found in the supernatant of collagen-HA-DTPH-PEGDA gels, suggesting that HMW HA facilitates contraction by effectively diffusing out of the collagen gels. Therefore, the results suggest that the crosslinking of HA-DTPH enhances the structural mechanics of collagen/ HA-DTPH composites, which resists the fibroblast contractile forces and may, therefore, be able to reduce excessive wound contraction observed in pathological conditions.
INTRODUCTION
During remodeling of a normally healing wound, myofibroblasts contract the wound edges by attaching to and pulling on the underlying collagen-rich matrix (Gabbiani et al., 1971 (Gabbiani et al., , 1976 . The compacted collagen fibers form intermolecular crosslinks resulting in the formation of straighter collagen bundles (clinically called ''scar'') than the basket-woven array of normal dermis. Unlike normal wounds where contraction ceases following myofibroblast apoptosis (Gabbiani, 2003; Grinnell, 2003) , burn wounds experience prolonged scar contraction owing to the continuous synthesis of collagen and its subsequent contraction by long-lived myofibroblasts, thereby leading to the formation of contractures (Grinnell, 1994) . Any biocompatible process or material that can prevent excessive collagen contraction would hold tremendous promise for the improved treatment of burn wounds with decrease or elimination of contractures.
Previous studies comparing normal adult and fetal wound healing processes have suggested that hyaluronan (HA) has a critical role in the regeneration or scarless repair of embryonic wounds (Longaker et al., 1989 (Longaker et al., , 1991 . HA is a naturally occurring, polyanionic, non-sulfated glycosaminoglycan composed of repeating disaccharide units of (a-1,4-Dglucuronic acid and b-1,3-N-acetyl-D-glucosamine) (Burd et al., 1989) . It occurs naturally in a wide range of MWs (MWs, 0.1-10 million Daltons) and concentrations, where the highest amount is found in skin tissue, which is approximately 50% of the total HA present in the body. In vivo, HA is stabilized by numerous link proteins (Hardingham and Fosang, 1992) . During both adult and embryonic wound healing, HA levels increase in concert with granulation tissue formation where it promotes cell migration and proliferation (Chen and Abatangelo, 1999) . While HA levels in normal adult wounds fall with the maturation of granulation tissue and initiation of the subsequent remodeling phase, they remain consistently elevated in fetal wounds (Longaker et al., 1990) . Therefore, increased and prolonged presence of HA in adult wounds may modulate the synthesis and organization of collagen fibers in a manner that resembles fetal wound healing.
An in vitro collagen gel contraction assay (Bell et al., 1979 (Bell et al., , 1983 simulates in vivo wound contraction. This model was subsequently used to elucidate the role of HA in modulating fibroblast contraction of collagen gels (Travis et al., 2001) . Surprisingly, HA was found to enhance collagen contraction in vitro, with the degree of contraction scaling linearly with HA concentration. This finding was counterintuitive from the prediction that HA might inhibit collagen contraction. However, native HA normally resides in conjunction with versican, an aggregating chondroitin sulfate proteoglycan that interacts with and stabilizes HA via link proteins (Sorrell et al., 1999) . The association of versican may be critical for the inhibitory effect of HA on wound contraction.
Consequently, in this study, we aimed to mimic the in vivo versican-mediated stability of HA via inter-molecular crosslinking of exogenous HA and investigate the effect on fibroblast contraction of collagen gels. Thiol-functionalized HA (HA-DTPH) (Shu et al., 2002) was added to collagen gels either directly or after crosslinking with poly(ethylene glycol) diacrylate (PEGDA) (Shu et al., 2004) , and its effect on gel contraction monitored. As the stability of a crosslinked network is known to depend not only on the MW and concentration of the macromer but also on the nature and density of effective crosslinks (Anseth et al., 1996) , we altered both the concentration and MW of the PEGDA crosslinker to study their effect on gel contraction. For comparison, native high molecular weight HA (HMW HA) was also separately added to gels and the corresponding contraction monitored. Cellular F-actin cytoskeleton was stained and visualized to determine and compare fibroblast morphology in the collagen or composite gels. As a further step towards understanding the mechanism of fibroblast-mediated contraction of these HA-collagen gels, the supernatant of contracted gels were evaluated for levels of HA released during gel contraction.
RESULTS

Dose response of PDGF on fibroblast-mediated collagen gel contraction
As reported previously, platelet-derived growth factor (PDGF) stimulated the contraction of fibroblast-populated collagen gels (Bell et al., 1979 (Bell et al., , 1983 . The gel diameters were measured at various time points and were plotted over a 48-hour period ( Figure 1 ). As expected, the fibroblastmediated collagen gel contraction occured in a PDGF dose-dependent manner with maximal contraction for 100 ng/ml PDGF and almost no contraction for the 0 ng/ml PDGF. Experiments were performed (data not shown) where the dose was increased to 300 ng/ml. The contraction of the gels reached a plateau at 100 ng/ml and increasing the dose beyond this concentration did not show any difference in contraction.
Effect of HMW and low molecular weight HA on collagen gel contraction HMW HA facilitated contraction of collagen gel as reported previously (Travis et al., 2001) . Gel contraction increased with increasing concentration of HMW HA (Figure 2b ), where the differences in final contraction between HMW HA concentrations were statistically significant (Po0.05). Contraction indices were 2.04 and 3.56 for 0.12 and 0.25% HA, respectively. Low MW HA, however, failed to show any significant effect (P40.05) on collagen gel contraction (Figure 2 ).
HA-DTPH inhibited collagen gel contraction
HA-DTPH alone inhibited contraction of collagen gels. Gel contraction decreased with increasing concentration of HA-DTPH (Figure 2c ), where the differences in final contraction between various HA-DTPH concentrations were statistically significant (Po0.05). Contraction Indices were À2.32 and À10.61 for 0.12 and 0.25% HA-DTPH, respectively. This inhibitory effect is not owing to any cytotoxic effects, as HA-DTPH has already been shown to be completely biocompatible (Shu et al., 2002; Liu et al., 2005) . This inhibition is likely caused by the formation of spontaneous, albeit slow, disulfide bonds that result from the air oxidation of free thiol groups on HA-DTPH. These disulfide bonds are irreversible in air and have been shown to crosslink a 1% HA-DTPH solution in approximately 4-6 hours (Shu et al., 2002; Ghosh et al., 2005) .
HA-DTPH-PEGDA inhibited collagen gel contraction
Altering PEGDA concentration (MW fixed at 3400 Da). PEGDA-crosslinked HA (HA-DTPH-PEGDA) hydrogel solutions www.jidonline.org 2203 of different crosslinking densities (2:1, 6:1, and 12:1) were mixed with collagen and allowed to gel in the presence of adult human dermal fibroblasts (AHDFs). All gels containing HA-DTPH-PEGDA showed a significant inhibition when compared with the controls (Figure 3 ), with the degree of inhibition increasing linearly with both HA-DTPH and PEGDA concentration. The contraction index varied significantly as the crosslinked ratio was altered (Table 1 ). Similar to HA-DTPH, the HA-DTPH-PEGDA solutions have also been shown to be completely cytocompatible before (Ghosh et al., 2006) . Gel contraction was compared in two ways: (a) between different HA-DTPH concentrations at each crosslinking density and (b) between different crosslinking densities at each HA-DTPH concentration. In both cases, the differences in gel contraction were found to be statistically significant (Po0.05). Table 1 shows the values of contraction indices obtained for the different concentrations and crosslinking ratios.
Altering PEGDA MW (crosslinking density fixed at 2:1). PEGDA with three different MWs (3400, 700, 258 Da) were used to prepare HA-DTPH-PEGDA constructs with a crosslinking density of 2:1 (Figure 4 ). The contraction index did not change substantially with a change in PEGDA MW (Table 2) , although the inhibition was significant (Po0.05) when compared with the control. In addition, for each MW of PEGDA, the difference in inhibition of gel contraction was statistically significant between different concentrations of HA-DTPH (Po0.05).
Temporal progression of composite gel contraction. Figure 5 shows the time course of the contraction of various composite gels. All HA-DTPH additives demonstrated an inhibitory effect right from the commencement of gel contraction, with the 0.25% HA-DTPH-PEGDA additive producing both the maximal and the fastest inhibition. Importantly, all but control collagen gels attained the terminally contracted state within 20 hours, indicating the stable nature of the crosslinked HA-DTPH network formed within the composite gels.
Fibroblast morphology
To determine whether the inhibition in gel contraction was caused by reduced cell attachment or spreading, we stained and visualized the fibroblast-populated gels at 4 and 24 hours post-contraction. As Figure 6 shows, fibroblast attachment HA-DTPH-PEGDA constructs were prepared using PEGDA MWs 258, 700, and 3400 Da, while fixing the crosslinking density at 2:1.
and spreading within collagen/HA-DTPH-PEGDA gels was similar to that within the control collagen gels at both time points. Furthermore, these images clearly demonstrate the inhibition in contraction of collagen/HA-DTPH-PEGDA gels as the average cell density per unit volume did not significantly change with incubation time. Fibroblast density within the control collagen gels, however, increased dramatically, which would be expected in a contracted collagen gel.
HA released into the supernatant during gel contraction
The amount of free HA in the supernatant of the collagen/ collagen-HA composite gels was quantitatively measured. Results (shown in Figure 7 ) indicate that the highest levels of HA were detected in gels receiving HMW HA, which was significantly higher than that observed in gels receiving either HA-DTPH or HA-DTPH-PEGDA. Although the level of supernatant HA was not statistically different for different HA concentrations (0.125 and 0.25%) within the same collagen-HA composite, the difference was significant (Po0.05) when different composites were compared at the same concentration. The experiment was performed in triplicates.
DISCUSSION
Apart from having a profound influence on cell behavior (Brecht et al., 1986) , HA also plays an important role in the structural characteristics of different tissues (Camenisch and McDonald, 2000) . From the perspective of extracellular matrix (ECM) remodeling, native HMW HA has been shown to facilitate collagen contraction by smooth muscle cells and adventitial fibroblasts in vitro (Travis et al., 2001) . It was speculated that this facilitation in contraction was owing to the increased interaction of cells with collagen resulting from the HA-CD44 binding and the subsequent chaperoning of collagen to the cell surface during cell internalization of native HMW HA. In this report, we investigated whether AHDFs contracted collagen-HA composites in a similar manner. In addition, we looked at the effect of adding two chemically modified derivatives of HA viz. HA-DTPH and the crosslinked HA-DTPH-PEGDA on the AHDF-mediated contraction of collagen gels. Adding HMW HA to collagen gels produced results similar to those reported previously (Travis et al., 2001) , where increasing HA concentration enhanced collagen gel contraction. This effect is attributed to the phenomenon called ''reptation''. Interestingly, both HA-DTPH and HA-DTPH-PEGDA inhibited collagen contraction, in a process that we call ''molecular stenting'', or ''nanostenting''. This finding might potentially lead to the treatment of pathological conditions (e.g. contractures) that involve excessive collagen contraction and remodeling.
The presence of HA in tissues stabilizes and is stabilized by other ECM components. In cartilage, for example, the aggrecan-HA linkage is crucial for HA stabilization and providing structural stability and rigidity to the native ECM (Hardingham, 1981) . Versican is another aggregating proteoglycan found in many soft connective tissues, including the dermis, (Hardingham, 1981) that aggregates with HA and retains it in tissues through complex interactions involving fibronectin and collagen (Sorrell et al., 1999) . In fact, versican is present in much larger quantities in the ECM of fetal skin as HA-DTPH-PEGDA additives were prepared at crosslinking density of 2:1 using PEGDA MW 3400 Da.
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Collagen Collagen /HA-DTPH-PEGDA Figure 6 . Phalloidin-stained fibroblasts seeded within collagen and collagen/ HA-DTPH-PEGDA gels. HA-DTPH was maintained at 0.25% (w/v), while PEGDA was added to obtain a 2:1 crosslinking density. No difference in cell morphology was observed with the addition of HA-DTPH-PEGDA. Average fibroblast density within control collagen gels increased drastically between 4 and 24 hours post-contraction, whereas that within the composite gels remained largely unchanged. Bar ¼ 10 mm. www.jidonline.org 2205 compared to adult skin (Sorrell et al., 1999) where it functions to interact with and stabilize HA (Yamagata et al., 1986; Sorrell et al., 1999) . Since the scarless or minimally scarred healing of fetal wounds, unlike adult wounds, is associated with consistently elevated levels of HA, we believe that versican's role in retaining HA within the cutaneous ECM is pivotal in guiding the remodeling of wound ECM in a manner reminiscent of regeneration. Presumably, both aggrecan and versican stabilize HA by acting as spacers or ''stents'', thereby providing HA with a structural support. Development of an HA-based biomaterial that can produce a similar effect during adult wound healing would, therefore, be greatly beneficial in preventing excessive or disorderly collagen remodeling as observed in pathological conditions following burn injuries.
In this report, we show that the application of crosslinked HA derivative prevents excessive collagen contraction in vitro. The global aim is to mimic the above-mentioned aggrecan-and versican-mediated stability of HA in native ECM by adding HA-DTPH, with or without PEGDA, to the collagen gels and investigating their fibroblast-mediated contraction. We hypothesized that both the spontaneous and the PEGDA-crosslinking of HA-DTPH would enhance the structural mechanics of the HA network in a way seen in the versican-rich fetal ECM. This hypothesis was validated by studies showing reduced levels of fibroblast-mediated collagen gel contraction that contained either HA-DTPH or HA-DTPH-PEGDA. Neither HA-DPTH nor PEGDA had any adverse effects on fibroblast attachment and spreading as judged by the immunoflourescence staining of cellular F-actin. The similar nature of fibroblast morphology in both collagen and collagen/HA-DTPH-PEGDA gels indicates that the magnitude of contractile forces would probably be similar. Hence, these findings strongly suggest that this marked inhibition in gel contraction results from a greater viscoelastic resistance produced by the more crosslinked HA-DTPH-PEGDA network, which is less pronounced in the disulfide-crosslinked network as shown in our previous rheological studies (Ghosh et al., 2005) . These data also correlate well with our understanding that both aggrecan and versican function by imparting greater structural stability to the HA network, which then manifests itself in the observed remodeling response.
Within the concentration range of 0.04-0.5%, HMW HA (1 MDa) shows concentration-dependent self-diffusion, which corresponds to the predicted behavior of polymer entanglement Hardingham, 1981, 2000) . Another study (Gribbon et al., 1999) showed that the selfdiffusion coefficient of HA decreases with an increase in concentration. Based on the fluorescence recovery after photobleaching analysis discussed in the latter report, we can safely assume that self-diffusion of HA chains did occur at the concentrations used in this study (0.12 and 0.25%). This, we hypothesized, would cause HMW HA to slither and ultimately diffuse out of the collagen matrix. If this were true, higher levels of HA would be present in the supernatant of collagen-HMW HA gels than those in the supernatant of either collagen-HA-DTPH or collagen-HA-DTPH-PEGDA gels. This was confirmed using the HA-ELISA kit that showed that at 48 hours post-contraction, levels of HA were greater in gels containing HMW HA as compared to those in gels containing HA-DTPH additives. This suggests that both spontaneous disulfide-crosslinking and PEGDA-crosslinking introduce ''nanostents'' within the HA network, similar to those produced by aggrecan and versican in native ECM, and enhance the structural stability and viscoelastic properties of the collagen gels. This, in turn, generates resistance to the fibroblast-generated contractile forces. This inhibition of gel contraction is not caused by the difference in MWs between native HMW HA and HA-DTPH since lower MW nonfunctionalized HA did not affect collagen gel contraction in any way.
We argued that if the inhibition in gel contraction is caused primarily owing to the intramolecular crosslinking of HA-DTPH/HA-DTPH-PEGDA network, the inhibitory effect should closely follow their crosslinking kinetics. Indeed, the inhibition trend observed during the temporal progression of gel contraction correlated inversely with the estimated crosslinking kinetics (Ghosh et al., 2005) of the respective HA-DTPH derivatives. For instance, HA-DTPH, which takes B4-6 hours to crosslink spontaneously, produced a significantly slower and weaker inhibition than HA-DTPH-PEGDA, which takes B10 minutes to crosslink. In addition, the inhibitory effect increased linearly with PEGDA (crosslinker) concentration, which lends further support to our assumption that inhibition is governed by the formation of a crosslinked network, the viscoelasticity of which is primarily controlled by the number of PEGDA-crosslinked junctions.
The effect of different PEGDA MWs (3400, 700, 258 Da) on contraction of collagen gels was also evaluated. No significant difference was observed in the extent of contraction. Even PEGDA of lower MWs (700 and 258 Da) demonstrated a very strong inhibitory effect. This shows that the inhibition in gel contraction is mainly dependent on the concentration, and not the MW, of PEGDA. This finding is consistent with the results from our recent rheological studies that have shown that the bulk mechanical properties of HA-DTPH-PEGDA hydrogels scale linearly with PEGDA concentration but are independent of its MW (Ghosh et al., 2005) . The same study also demonstrated the weak nature of the spontaneously disulfide-bond crosslinked HA-DTPH network. These results substantiate our current results where HA-DTPH additives produced a weaker inhibition when compared to HA-DTPH-PEGDA additives.
Although additional in vitro and in vivo studies need to be conducted to fully realize the potential of HA-DTPH-PEGDA biomaterials in preventing excessive collagen contraction in patients with burns, we believe that this study will act as an excellent platform to launch such experimentation.
MATERIALS AND METHODS
Cell culture
Primary AHDFs were obtained from Clonetics (San Diego, CA) and used between passages 5 and 13. The cells were routinely cultured in DMEM (Sigma) supplemented with 10% fetal bovine serum (HyClone, Logan, UT) and an antibiotic (Gibco BRL, Grand Island, NE) mix of penicillin, streptomycin, and L-glutamine, in a 371C, 5% CO 2 /95% humidity incubator (Napco Scientific Company, Tualatin, OR). Regardless of the functional assay, the AHDF monolayers were grown to nearly 80% confluence, harvested, then centrifuged to obtain a pellet that was rinsed twice with serum-free DMEM þ 2% bovine serum albumin (fraction V, ICN Biomedicals, CT), and finally resuspended in serum-free DMEM or DMEM supplemented with 10% fetal bovine serum and an antibiotic mix of penicillin, streptomycin, and L-glutamine for use in functional assays.
HA-DTPH
HA-DTPH (Figure 8a ) was synthesized as described previously (Shu et al., 2002) . Both the degree of substitution and the free thiol content of HA-DTPH (determined by nuclear magnetic resonance and modified Ellman's method, respectively) were found to be approximately 42%, indicating that the remaining 58% of the HA disaccharide units contained the native carboxylic acid group.
Specimen preparation
Fibroblast-populated collagen gels. Fibroblasts were re-suspended at a concentration of 1.5 Â 10 6 cells/ml and mixed with neutralized bovine skin collagen (Vitrogen, Collagen Corp., Paolo Alto, CA), serum, and concentrated DMEM to obtain the final concentrations of 1.8 mg/ml, 5%, and 1 Â , respectively. Human plasma fibronectin (Chemicon International Inc., Temecula, CA) and PDGF-BB (Ortho-McNeil, Raritan, NJ) were added to the fibroblast-collagen mix at a final concentration of 30 mg/ml and 100 ng/ ml, respectively. Fibroblast-collagen mixture (600 ml) was then plated into the wells of a 24-well plate (Falcon, BD Biosciences, Franklin Lakes, NJ), which was pre-coated with 2% BSA, and the collagen gel was allowed to polymerize at 371C. The final fibroblast density was 90,000 cells/well, which was determined to be optimal for this assay (data not shown). After 2 hours incubation, the gels were gently detached from the plastic surface to allow contraction (Figure 9a ), and 500 ml of medium was added per well. The gels were then incubated overnight at 371C in 5% CO 2 . www.jidonline.org 2207 TD Mehra et al.
HA-DTPH stock solution (in serum-free DMEM, pH 7.4) were added to one volume of corresponding PEGDA stock solution (in phosphate-buffered saline, pH 7.4) and the solutions mixed for 30 seconds at room temperature. Under these conditions, the gelation time for the various HA-DTPH-PEGDA solutions increases with decrease in crosslinking density, while being independent of the PEGDA MW (Shu et al., 2004; Ghosh et al., 2005) . These pregelling solutions were quickly added to the fibroblast-populated collagen solution and the final fibroblast/HA-collagen mix plated into the wells of a 24-well plate. HA-free collagen gels were always used as controls. Wherever appropriate, gel contraction was monitored temporally.
Immunofluorescence staining
Fibroblast-populated collagen or collagen/HA-DTPH (0.25%)-PEG-DA (2:1) composite gels were allowed to contract for 4 or 24 hours post-stimulation with 5% fetal bovine serum. At the end of each time point, samples were fixed with 3.7% formaldehyde and permeabilized with a mild detergent, 1% Nonidet-P40 (Sigma). Cellular F-actin was then stained with a 1:100 dilution of Alexa Fluor-488 labeled phalloidin (Molecular Probes; Invitrogen Corporation, Carlsbad, CA), whereas DAPI (300 nM, Molecular Probes) was used to stain nuclei. Images were acquired with a MetaMorph software (Molecular Devices, Sunnyvale, CA) using 20 Â objective of a widefield fluorescent microscope (Nikon diaphot TMD).
HA in solution
The amount of HA in the supernatant of contracted collagen-HA gels was quantified using a competitive binding HA-ELISA kit (Echelon Biosciences, Salt Lake City, UT). In this inverse colorimetric assay, a lower absorbance value indicates a higher quantity of HA. As higher amounts of HA would result in values very close to the zero reading and hence prone to errors, all samples were used at 1:10 and 1:100 dilutions. Samples to be assayed were first mixed with the detector, and then added to the HA-ELISA plate for competitive binding. An enzyme-linked antibody and colorimetric detection was then used to detect the HA detector bound to the plate. The concentration of HA in the sample was determined using a standard curve generated using known amounts of HA.
Statistics
All collagen-HA composite assays were performed in triplicate (n ¼ 3) and the data for the area of the contracted gels was represented as mean7SD for each experiment. The data shown are representative of additional experiments performed. Results were compared using the Kruskal-Wallis test (for non-parametric independent group comparisons). The Analyse-it statistical software was used for analysis. The level of significance was assigned at Po0.05.
Contraction index
The contraction index of experimental gels was calculated as:
where (A 0 ÀA 1 ) E ¼ difference between initial area (t ¼ 0) and final area (t ¼ 48 hours) of experimental (A 0 ÀA 1 ) C ¼ difference between initial area (t ¼ 0) and final area (t ¼ 48 hours) of control.
